Title: An exploratory study of neovaginal and rectal HIV transmission risks and the feasibility of collection of biological specimens for microbiological, immunological and cytological characterization in the context of antiretroviral chemoprophylaxis for the prevention of HIV infection in post- operative transgender women. Status: Ongoing
What is EN-V study?
Exploration of the Neo-vagina study (EN-V) is the study to explore neovaginal and rectal HIV transmission risks and assess the feasibility of collecting biological specimens from post-operative transgender women for microbiological, immunological and cytological analysis.
Why is EN-V study important?
Transgender women are more prone to HIV and STI infections, especially for post-operative TG. However, very little is known about the sexual practices and genital health of TG, including penile, rectal and neo-vaginal health. We hope the study will shed light on the health of non-operative, pre- operative and post-operative (non-op, pre-op and post-op) TG. Moreover, the results will help design future biomedical HIV prevention research among TG, and to inform a TG specific health research agenda and health care programming.
Who will be participating in EN-V study?
EN-V study will enroll 40 post-operative and 60 pre-and non-operative TG ages 18 and older. The participants will be enrolled for 5 years, with one follow-up visit every year.
*The study is sponsored by amfAR TREAT Asia
HPTN083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected men and transgender women who have sex with men (MSM and TGW).
Gardasil Immunogenicity with Needle-free Injection (GINI) was a study to evaluate the safety and effectiveness of two HPV vaccine delivery regimens; by needle and syringe and needle free jet injection.
ATS is a study being done to evaluate the pattern of amphetamine-type use (ATS) by HIV status and the associated demographic and behavioral risk characteristics. The effect of ATS use on HIV and STI incidence among HIV-negative and antiretroviral adh
ANSAP is a study to determine the prevalence and incidence of anal HPV infection and high-grade anal intraepithelial neoplasia (HGAIN), and evaluate their risk factors, among HIV-positive and HIV-negative men who have sex with men (MSM) in Indonesia,